|Articles|July 1, 2015
Biologics Development and Manufacturing Trends, Part 2
Eric Langer, Managing partner at BioPlan Associates, speaks with BioPharm International about biosimilar development trends.
Advertisement
Eric Langer, Managing Partner at BioPlan Associates, spoke with BioPharm International about biosimilar development trends.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
3
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
4
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
5